Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Heaphy

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
Cancers|June 24, 2022
Therapeutic Vulnerability to ATR Inhibition in Concurrent <i>NF1</i> and <i>ATRX</i>-Deficient/ALT-Positive High-Grade Solid TumorsMing Yuan, Charles G Eberhart, Christine A Pratilas, et al.
International Journal of Cancer|November 25, 2010
Markers of fibrosis and epithelial to mesenchymal transition demonstrate field cancerization in histologically normal tissue adjacent to breast tumorsKristina A Trujillo, Christopher M Heaphy, Minh Mai, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 15, 2020
High Extratumoral Mast Cell Counts Are Associated with a Higher Risk of Adverse Prostate Cancer OutcomesHeidi Hempel Sullivan, Christopher M Heaphy, Ibrahim Kulac, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 8, 2018
Cocaine use may induce telomere shortening in individuals with HIV infectionShenghan Lai, Christopher M Heaphy, Anthony J Rizzo, et al.
Endocrine-Related Cancer|March 21, 2025
Management of patients with small pancreatic neuroendocrine tumors from a biomarker and surgical perspectiveAnna Vera D Verschuur, Lin Chen, Els J Nieveen van Dijkum, et al.
Breast Cancer Research and Treatment|June 6, 2006
Telomere content correlates with stage and prognosis in breast cancerColleen A Fordyce, Christopher M Heaphy, Marco Bisoffi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 10, 2020
Racial Difference in Prostate Cancer Cell Telomere Lengths in Men with Higher Grade Prostate Cancer: A Clue to the Racial Disparity in Prostate Cancer OutcomesChristopher M Heaphy, Corinne E Joshu, John R Barber, et al.
The Prostate|November 29, 2013
Telomere length as a risk factor for hereditary prostate cancerLauren M Hurwitz, Christopher M Heaphy, Corinne E Joshu, et al.
The Prostate|October 18, 2023
Chromogenic detection of telomere lengths in situ aids the identification of precancerous lesions in the prostateOnur Ertunc, Erica Smearman, Qizhi Zheng, et al.
Journal of Neuropathology and Experimental Neurology|November 29, 2025
RECQL4 alterations in gliomas and nerve sheath tumors: Expression patterns and therapeutic implicationsSarra Belakhoua, Gianluca Lopez, Swati Dubey, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Cancers|June 24, 2022
Therapeutic Vulnerability to ATR Inhibition in Concurrent <i>NF1</i> and <i>ATRX</i>-Deficient/ALT-Positive High-Grade Solid TumorsMing Yuan, Charles G Eberhart, Christine A Pratilas, et al.
International Journal of Cancer|November 25, 2010
Markers of fibrosis and epithelial to mesenchymal transition demonstrate field cancerization in histologically normal tissue adjacent to breast tumorsKristina A Trujillo, Christopher M Heaphy, Minh Mai, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 15, 2020
High Extratumoral Mast Cell Counts Are Associated with a Higher Risk of Adverse Prostate Cancer OutcomesHeidi Hempel Sullivan, Christopher M Heaphy, Ibrahim Kulac, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 8, 2018
Cocaine use may induce telomere shortening in individuals with HIV infectionShenghan Lai, Christopher M Heaphy, Anthony J Rizzo, et al.
Endocrine-Related Cancer|March 21, 2025
Management of patients with small pancreatic neuroendocrine tumors from a biomarker and surgical perspectiveAnna Vera D Verschuur, Lin Chen, Els J Nieveen van Dijkum, et al.
Breast Cancer Research and Treatment|June 6, 2006
Telomere content correlates with stage and prognosis in breast cancerColleen A Fordyce, Christopher M Heaphy, Marco Bisoffi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 10, 2020
Racial Difference in Prostate Cancer Cell Telomere Lengths in Men with Higher Grade Prostate Cancer: A Clue to the Racial Disparity in Prostate Cancer OutcomesChristopher M Heaphy, Corinne E Joshu, John R Barber, et al.
The Prostate|November 29, 2013
Telomere length as a risk factor for hereditary prostate cancerLauren M Hurwitz, Christopher M Heaphy, Corinne E Joshu, et al.
The Prostate|October 18, 2023
Chromogenic detection of telomere lengths in situ aids the identification of precancerous lesions in the prostateOnur Ertunc, Erica Smearman, Qizhi Zheng, et al.
Journal of Neuropathology and Experimental Neurology|November 29, 2025
RECQL4 alterations in gliomas and nerve sheath tumors: Expression patterns and therapeutic implicationsSarra Belakhoua, Gianluca Lopez, Swati Dubey, et al.
Pageof 12